全文获取类型
收费全文 | 8839篇 |
免费 | 630篇 |
国内免费 | 17篇 |
专业分类
耳鼻咽喉 | 36篇 |
儿科学 | 238篇 |
妇产科学 | 85篇 |
基础医学 | 972篇 |
口腔科学 | 328篇 |
临床医学 | 1156篇 |
内科学 | 1636篇 |
皮肤病学 | 53篇 |
神经病学 | 810篇 |
特种医学 | 293篇 |
外科学 | 962篇 |
综合类 | 539篇 |
一般理论 | 12篇 |
预防医学 | 1017篇 |
眼科学 | 252篇 |
药学 | 713篇 |
中国医学 | 3篇 |
肿瘤学 | 381篇 |
出版年
2023年 | 45篇 |
2022年 | 66篇 |
2021年 | 177篇 |
2020年 | 104篇 |
2019年 | 151篇 |
2018年 | 215篇 |
2017年 | 139篇 |
2016年 | 176篇 |
2015年 | 176篇 |
2014年 | 234篇 |
2013年 | 376篇 |
2012年 | 614篇 |
2011年 | 717篇 |
2010年 | 365篇 |
2009年 | 326篇 |
2008年 | 598篇 |
2007年 | 693篇 |
2006年 | 604篇 |
2005年 | 619篇 |
2004年 | 611篇 |
2003年 | 604篇 |
2002年 | 528篇 |
2001年 | 139篇 |
2000年 | 107篇 |
1999年 | 106篇 |
1998年 | 111篇 |
1997年 | 69篇 |
1996年 | 70篇 |
1995年 | 65篇 |
1994年 | 59篇 |
1993年 | 64篇 |
1992年 | 56篇 |
1991年 | 47篇 |
1990年 | 44篇 |
1989年 | 36篇 |
1988年 | 34篇 |
1987年 | 27篇 |
1986年 | 46篇 |
1985年 | 31篇 |
1984年 | 27篇 |
1983年 | 32篇 |
1982年 | 26篇 |
1980年 | 14篇 |
1979年 | 24篇 |
1978年 | 14篇 |
1976年 | 8篇 |
1974年 | 10篇 |
1971年 | 8篇 |
1970年 | 8篇 |
1968年 | 7篇 |
排序方式: 共有9486条查询结果,搜索用时 15 毫秒
11.
E Scarr P H Yu B A Davis A A Boulton 《Progress in neuro-psychopharmacology & biological psychiatry》1991,15(2):297-301
1. Studies were carried out on three monoamine oxidase (MAO) inhibitors, two of which, debrisoquine and para- hydroxyphenelzine, are purported to be peripheral inhibitors and one, phenelzine, is a peripherally acting inhibitor, which has been included for comparitive purposes. 2. All three showed varying degrees of specificity towards MAO type A. 3. The action of debrisoquine was very rapid as was that of para- hydroxyphenelzine. 4. The inhibition caused by debrisoquine was competitive and reversible, while that caused by both phenelzine and para- hydroxyphenelzine was irreversible. 5. The inhibition caused by debrisoquine appeared to be unaffected by the pH of the medium. 相似文献
12.
Kevin O'Brien Jean Wright Frances Conboy YeWeng Sanjie Nicky Mandall Stephen Chadwick Ivan Connolly Paul Cook David Birnie Mark Hammond Nigel Harradine David Lewis Cathy McDade Laura Mitchell Alison Murray Julian O'Neill Mike Read Stephen Robinson Dai Roberts-Harry Jonathan Sandler Ian Shaw 《American journal of orthodontics and dentofacial orthopedics》2003,124(3):234-43; quiz 339
This study evaluated the effectiveness of early orthodontic treatment with the Twin-block appliance for the developing Class II Division 1 malocclusion. This multicenter trial was carried out in the United Kingdom. A total of 174 children, aged 8 to 10 years old, with Class II Division 1 malocclusion were randomly allocated to receive treatment with a Twin-block appliance or to an untreated, control group. Data were collected at the start of the study and 15 months later. Results showed that early treatment with Twin-block appliances resulted in reduction of overjet, correction of molar relationships, and reduction in severity of malocclusion. Most of this correction was due to dentoalveolar change, but some was due to favorable skeletal change. Early treatment with the Twin-block appliance is effective in reducing overjet and severity of malocclusion. The small change in the skeletal relationship might not be considered clinically significant. 相似文献
13.
Retinal and preretinal localisation of epidermal growth factor, transforming growth factor alpha, and their receptor in proliferative diabetic retinopathy. 总被引:7,自引:3,他引:4
下载免费PDF全文
![点击此处可从《The British journal of ophthalmology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
B Patel P Hiscott D Charteris J Mather D McLeod M Boulton 《The British journal of ophthalmology》1994,78(9):714-718
A number of growth factors have been implicated in the development and perpetuation of preretinal fibrovascular membranes in patients with proliferative diabetic retinopathy (PDR). The aim of this study was to determine the potential role of epidermal growth factor (EGF), transforming growth factor alpha (TGF-alpha), and their receptor (EGF-R) in PDR development. Immunostaining for EGF, TGF-alpha, and EGF-R was compared between normal retina, PDR retina, and PDR preretinal membranes. Weak staining for EGF and EGF-R was observed throughout the neural retina from non-diabetic eyes while weak to moderate staining for TGF-alpha was observed in the ganglion cell layer and the inner and outer nuclear layers. In contrast, intense staining for EGF and TGF-alpha and moderate staining for EGF-R were observed throughout the PDR retina. Immunoreactivity for EGF, TGF-alpha, and EGF-R was seen in the majority of the 11 excised membranes studied and, though variable, was generally greater than that observed in normal retinas. These results suggest an autocrine/paracrine role for EGF, TGF-alpha, and EGF-R in PDR. 相似文献
14.
PET for evaluation of differential myocardial perfusion dynamics after VEGF gene therapy and laser therapy in end-stage coronary artery disease. 总被引:2,自引:0,他引:2
René A Tio Eng S Tan Gillian A J Jessurun Nic Veeger Pieter L Jager Riemer H J A Slart Richard M de Jong Jan Pruim Geke A P Hospers Antoon T M Willemsen Mike J L de Jongste Ad J van Boven Dirk J van Veldhuisen Felix Zijlstra 《Journal of nuclear medicine》2004,45(9):1437-1443
The purpose of this study was to appraise the value of PET in the assessment of the effect of supposedly proangiogenic new therapies such as gene therapy with vascular endothelial growth factor (VEGF) gene and endomyocardial laser therapy. METHODS: Thirty-five patients with end-stage coronary artery disease and class III (Canadian Cardiovascular Society) angina were included. Myocardial ischemia was evaluated with dipyridamole PET scanning and exercise tolerance with bicycle ergometry. Ten patients were treated with naked plasmid DNA encoding for human VEGF165 (VEGF) and 12 patients were treated with laser therapy (direct myocardial revascularization [DMR]) using an electromechanical mapping system. Thirteen patients were treated with standard medical therapy (control). RESULTS: In both active treatment groups, angina was reduced in most subjects, except in 2 VEGF and 5 DMR patients. In the control group, no improvement in anginal classification was found, except in 3 subjects. On the PET scan, solely in the VEGF group, the stress perfusion was significantly improved (from 57 +/- 33 to 81 +/- 55 mL/min/100 g; P = 0.031). Furthermore, in the VEGF group, the number of ischemic segments was reduced from 274 +/- 41 to 234 +/- 48 segments (P = 0.004) but not in the DMR group (from 209 +/- 43 to 215 +/- 52 segments) or in the control group (from 218 +/- 18 to 213 +/- 28 segments). Bicycle exercise duration showed slight nonsignificant changes in the VEGF group (from 3.6 +/- 2.0 to 4.6 +/- 2.1 min), in the DMR group (from 5.1 +/- 1.5 to 4.7 +/- 1.3 min), and in the control group (from 3.3 +/- 1.8 to 3.5 +/- 2.3 min). CONCLUSION: PET showed that intramyocardial gene therapy with the human VEGF165 gene in contrast to laser DMR treatment effectively reduces myocardial ischemia. 相似文献
15.
16.
17.
18.
Stephen R. Kisely Mike Wise Neil Preston Senia Malmgren Peter Shannon 《Australian and New Zealand journal of public health》2003,27(3):261-263
Objectives: To evaluate a group intervention to help individuals with psychiatric disorder stop smoking.
Method: A waitlist-treatment crossover design. Outcome measures included smoking cessation, motivation to stop, the Fagerstrom Test for Nicotine Dependence (FTND), urinary cotinine and psychiatric symptoms on the General Health Questionnaire.
Results: 38 subjects participated, of whom 19 completed the waitlist and intervention phases. There were no significant differences between subjects and dropouts. During the waitlist period there were no significant changes in tobacco use. At the end of the intervention, almost a quarter had stopped smoking, ( z = -2.24, p =0.02). Subjects also showed significant improvements on state of change, FTND score and urinary cotinine levels. These improvements were maintained at three-month follow-up (n=10). Psychiatric morbidity showed no change.
Conclusions: It is possible to reduce smoking in individuals with psychiatric disorder.
Implications: Larger randomised controlled trials are indicated to determine the relative contributions of nicotine replacement, bupropion and group interventions to smoking cessation in this population. 相似文献
Method: A waitlist-treatment crossover design. Outcome measures included smoking cessation, motivation to stop, the Fagerstrom Test for Nicotine Dependence (FTND), urinary cotinine and psychiatric symptoms on the General Health Questionnaire.
Results: 38 subjects participated, of whom 19 completed the waitlist and intervention phases. There were no significant differences between subjects and dropouts. During the waitlist period there were no significant changes in tobacco use. At the end of the intervention, almost a quarter had stopped smoking, ( z = -2.24, p =0.02). Subjects also showed significant improvements on state of change, FTND score and urinary cotinine levels. These improvements were maintained at three-month follow-up (n=10). Psychiatric morbidity showed no change.
Conclusions: It is possible to reduce smoking in individuals with psychiatric disorder.
Implications: Larger randomised controlled trials are indicated to determine the relative contributions of nicotine replacement, bupropion and group interventions to smoking cessation in this population. 相似文献
19.
Kate Windridge Carolyn Tarrant George K Freeman Richard Baker Mary Boulton Janet Low 《The British journal of general practice》2004,54(502):364-366
We report an analysis of the qualitative phase of a study of patients' and carers' views of primary care services, focusing on their experiences of access to face-to-face general practitioner (GP) consultations during the period when new access policies were being implemented. Practices interpreted the new policy in various ways; restricted interpretations, including restriction of access to telephone booking, could cause distress to patients. Patients and carers welcomed flexible interpretations of the policy that offered choice, such as a choice of GP, or of booking in advance. 相似文献
20.